Recent Small-Molecule Inhibitors of the p53–MDM2 Protein–Protein Interaction
This review presents the last decade of studies on the synthesis of various types of small-molecule inhibitors of the p53– Mouse double minute 2 homolog (MDM2) protein–protein interaction. The main focus is placed on synthetic approaches to such molecules, their cytotoxicity, and MDM2 binding charac...
Main Authors: | Anastasia Beloglazkina, Nikolai Zyk, Alexander Majouga, Elena Beloglazkina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/5/1211 |
Similar Items
-
A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma
by: Hanjie Yi, et al.
Published: (2018-05-01) -
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
by: Yuan Fang, et al.
Published: (2020-07-01) -
Controlling the Mdm2-Mdmx-p53 Circuit
by: David L. Waning, et al.
Published: (2010-05-01) -
Regulation of the tumor suppressor p53 by Mdm2 and Mdm4
by: Maetens, Marion
Published: (2007) -
First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models
by: Seyed Pairawan, et al.
Published: (2021-03-01)